GlobalData has released its new
Country report, PharmaPoint: Meningococcal Vaccines United Kingdom Drug
Forecast and Market Analysis to 2022. Meningococcal disease is an acute
infection caused by the gram-negative bacterium Neisseria meningitidis. Its
rapid onset and severity of symptoms makes prompt and effective diagnosis and
treatment nearly impossible. For these reasons the meningococcal disease space
is dominated by vaccines. Currently, tetravalent conjugate vaccines, such as
Sanofis Menactra and Novartis Menveo, account for the vast majority of global
sales, with the US adolescent market being the key target segment. GlobalData
expects growth in the meningococcal vaccines market to be primarily driven by
the launch of serotype B vaccines, which address a critical unmet need in the
treatment landscape. Vaccines that better protect infants and/or provide a
longer duration of immunity also have an opportunity to seize market share
during 2012-2022.
GlobalData predicts that relative
patient share for the three MenC conjugate vaccines will shift due to changes
being made to the UK MenC schedule (DOH, 2013b). Meningitec will lose sales due
to its elimination from the single primary dose, with patient share expected to
be made up by Menjugate and NeisVac-C.
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/pharmapoint-meningococcal-vaccines-united-kingdom-drug-forecast-and-market-analysis-to-2022
Scope
- Overview of Meningococcal Vaccines including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in the UK including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in the UK from 2012-2022.
- Analysis of the impact of key events as well the drivers and restraints affecting the UK Meningococcal Vaccines market.
Reasons to buy
- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for Meningococcal Vaccines
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of drug performance
- Obtain sales forecast for drugs from 2012-2022 in the UK
About Us
MarketResearchReports.Biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948
Blog: http://industry-research-reports.blogspot.com/
No comments:
Post a Comment